Literature DB >> 17010399

Toxoplasma meningoencephalitis in HIV-seronegative patients: clinical patterns, imaging features and treatment outcome.

Sunil Pradhan1, Ramakant Yadav, Vijay Nath Mishra.   

Abstract

We evaluated the clinical and imaging features of cranial toxoplasmosis in patients without HIV infection. Between 1995 and 2005, 15 patients with serologically proven cranial toxoplasmosis were selected for clinical and imaging study from 233 patients with chronic meningitis and 364 patients with seizures/psychosis. All patients had poor immune status due to nutritional and metabolic causes. Neurological presentations included focal encephalitis, multifocal encephalitis and diffuse meningoencephalitis. The three groups had distinct symptoms and imaging features, with some overlap. Magnetic resonance imaging showed single or multiple nodular or ring-enhancing lesions often at the grey-white junction with subcortical white matter perifocal oedema. Within the large diffuse lesions there were discrete small haemorrhagic lesions and contrast medium administration showed fine-beaded parallel lines or small discrete nodules traversing the white matter suggesting perivenous spread. Complete clinical recovery was noted in 12 patients after several 6-week courses of pyrimethamine and sulfonamide/clindamycin. Five patients required two such courses, three patients required three courses, three patients required five courses and two patients required six courses for the final radiological healing, which was complete in nine patients. One patient was lost to follow-up and one patient died of cardiomyopathy. Knowledge of these three distinct initial presentations may help in the early diagnosis of cranial toxoplasmosis in HIV-seronegative patients. Prognosis in early cases is generally good but complete recovery may need several courses of treatment.

Entities:  

Mesh:

Year:  2006        PMID: 17010399     DOI: 10.1016/j.trstmh.2006.02.021

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  10 in total

1.  Toxoplasma gondii meningoencephalitis without cerebral MRI findings in a patient with ulcerative colitis under immunosuppressive treatment.

Authors:  S F Assimakopoulos; V Stamouli; D Dimitropoulou; A Spiliopoulou; G Panos; E D Anastassiou; M Marangos; I Spiliopoulou
Journal:  Infection       Date:  2015-01-27       Impact factor: 3.553

Review 2.  Importance of nonenteric protozoan infections in immunocompromised people.

Authors:  J L N Barratt; J Harkness; D Marriott; J T Ellis; D Stark
Journal:  Clin Microbiol Rev       Date:  2010-10       Impact factor: 26.132

Review 3.  Video Anthology of Movement Disorders Due to Infections in South Asia.

Authors:  Annu Aggarwal; Sachin Adukia; Mohit Bhatt
Journal:  Mov Disord Clin Pract       Date:  2021-07-18

4.  Donor CD8+ T cells prevent Toxoplasma gondii de-encystation but fail to rescue the exhausted endogenous CD8+ T cell population.

Authors:  Rajarshi Bhadra; Dustin A Cobb; Imtiaz A Khan
Journal:  Infect Immun       Date:  2013-07-01       Impact factor: 3.441

5.  Latent toxoplasmosis in patients with different malignancy: a hospital based study.

Authors:  Amal Nimir; Amizah Othman; Soon Ee; Zohdy Musa; Iffah Abd Majid; Zalikha Kamarudin; Chee Xian; Noor Hayati Isa
Journal:  J Clin Med Res       Date:  2010-05-19

6.  Lack of Association Between Toxoplasma gondii Infection and Diabetes Mellitus: A Matched Case-Control Study in a Mexican Population.

Authors:  Cosme Alvarado-Esquivel; Nayely Loera-Moncivais; Jesus Hernandez-Tinoco; Luis Francisco Sanchez-Anguiano; Guillermina Hernandez-Madrid; Elizabeth Rabago-Sanchez; Maria Magdalena Centeno-Tinoco; Ada A Sandoval-Carrillo; Jose M Salas-Pacheco; Oscar Vladimir Campos-Moreno; Elizabeth Irasema Antuna-Salcido
Journal:  J Clin Med Res       Date:  2017-04-26

Review 7.  Catastrophic consequences: can the feline parasite Toxoplasma gondii prompt the purrfect neuroinflammatory storm following traumatic brain injury?

Authors:  Tamara L Baker; Mujun Sun; Bridgette D Semple; Shiraz Tyebji; Christopher J Tonkin; Richelle Mychasiuk; Sandy R Shultz
Journal:  J Neuroinflammation       Date:  2020-07-25       Impact factor: 8.322

8.  Association between Toxoplasma gondii infection and history of blood transfusion: a case-control seroprevalence study.

Authors:  Cosme Alvarado-Esquivel; Luis Francisco Sánchez-Anguiano; Jesús Hernández-Tinoco; Agar Ramos-Nevarez; Sergio Estrada-Martínez; Sandra Margarita Cerrillo-Soto; Gonzalo Elías Medina-Heredia; Carlos Alberto Guido-Arreola; Araceli Alejandra Soto-Quintero; Isabel Beristain-Garcia
Journal:  J Int Med Res       Date:  2018-03-01       Impact factor: 1.671

9.  Erdheim-Chester Disease Involving the Central Nervous System with Latent Toxoplasmosis.

Authors:  Tomoya Wadayama; Mikito Shimizu; Ikko Kimura; Kousuke Baba; Goichi Beck; Seiichi Nagano; Ryo Morita; Hidenori Nakagawa; Michinori Shirano; Tetsushi Goto; Kazumi Norose; Kenji Hikosaka; Shigeo Murayama; Hideki Mochizuki
Journal:  Intern Med       Date:  2022-02-08       Impact factor: 1.282

10.  Novel triazine JPC-2067-B inhibits Toxoplasma gondii in vitro and in vivo.

Authors:  Ernest J Mui; Guy A Schiehser; Wilbur K Milhous; Honghue Hsu; Craig W Roberts; Michael Kirisits; Stephen Muench; David Rice; J P Dubey; Joseph W Fowble; Pradipsinh K Rathod; Sherry F Queener; Susan R Liu; David P Jacobus; Rima McLeod
Journal:  PLoS Negl Trop Dis       Date:  2008-03-05
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.